Background: The US Alzheimer’s Disease Centers (ADCs) (n = 30) recently created a uniform data set. We sought to determine which variables were most important in making a diagnosis, and how these differed across ADCs. Methods: A cross-sectional analysis of first visits to ADCs via polytomous logistic regression. We analyzed subjects with complete data (n = 7,555, 89%), and also used multiple imputation to infer missing data. Results: There were 8,495 subjects; 50, 26, and 24% were diagnosed as normal, having mild cognitive impairment (MCI), or mild Alzheimer’s disease [Clinical Dementia Rating (CDR) score <1], respectively. The model using 7,555 subjects was 86% accurate in predicting diagnosis. Important predictors were physician-reported decline and the CDR sum of boxes, followed by 4 cognitive tests (Mini Mental State Examination, Category Fluency Tests, Logical Memory Test, Boston Naming Test). Multiple imputation revealed Trail Making Test B to be additionally important. Consensus versus single-clinician diagnoses were 2–3 times more likely to result in MCI than normal diagnoses. Excluding clinical judgment variables, functional assessment and psychiatric symptoms were important additional predictors; model accuracy remained high (78%). There were significant differences between centers in the use of different cognitive tests in making diagnoses. Conclusions: We recommend creating a hypothetic data set to use across ADCs to improve diagnostic consistency, and a survey on the use of raw or adjusted cognitive test scores by different ADCs.

Keywords:
Alzheimer’s disease, Mild cognitive impairment, Cognition
This content is only available via PDF.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.